Terug
53
Dagbereik
€ 45,05
€ 46,06
52-Weeksbereik
€ 29,66
€ 47,86
Volume
3.312.388
50D / 200D Gem.
€ 43,70
/
€ 38,65
Vorige Slotkoers
€ 45,36
Koershistorie
Financiële Trends
Sectorvergelijking
vs Healthcare sector mediaan (626 peers)
| Metriek | Aandeel | Sector Mediaan |
|---|---|---|
| P/E | 25,4 | 0,4 |
| P/B | 3,0 | 2,9 |
| ROE % | 11,5 | 3,7 |
| Net Margin % | 32,4 | 3,8 |
| Rev Growth 5Y % | 1,0 | 10,0 |
| D/E | 1,4 | 0,2 |
Belangrijkste Punten
Revenue grew 0,96% annually over 5 years — modest growth
Earnings declined -10,25% over the past year
ROE of 11,49% — decent returns on equity
Net margin of 32,42% shows strong profitability
Generating 2,49B in free cash flow
Revenue growth is accelerating — 1Y growth exceeds 5Y average by 4,10%
Groei
Revenue Growth (5Y)
0,96%
Revenue (1Y)5,06%
Earnings (1Y)-10,25%
FCF Growth (3Y)-8,71%
Kwaliteit
Return on Equity
11,49%
ROIC7,58%
Net Margin32,42%
Op. Margin65,58%
Veiligheid
Debt / Equity
1,38
Current Ratio0,97
Interest Coverage5,07
Waardering
P/E Ratio
25,35
P/B Ratio3,02
EV/EBITDA17,87
Dividend Yield0,02%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | 5,06% | Revenue Growth (3Y) | 0,50% |
| Earnings Growth (1Y) | -10,25% | Earnings Growth (3Y) | -17,58% |
| Revenue Growth (5Y) | 0,96% | Earnings Growth (5Y) | 5,61% |
| Profitability | |||
| Revenue (TTM) | 2,38B | Net Income (TTM) | 770,95M |
| ROE | 11,49% | ROA | 3,93% |
| Gross Margin | 100,00% | Operating Margin | 65,58% |
| Net Margin | 32,42% | Free Cash Flow (TTM) | 2,49B |
| ROIC | 7,58% | FCF Growth (3Y) | -8,71% |
| Safety | |||
| Debt / Equity | 1,38 | Current Ratio | 0,97 |
| Interest Coverage | 5,07 | Dividend Yield | 0,02% |
| Valuation | |||
| P/E Ratio | 25,35 | P/B Ratio | 3,02 |
| P/S Ratio | 8,22 | PEG Ratio | 1,04 |
| EV/EBITDA | 17,87 | Dividend Yield | 0,02% |
| Market Cap | 19,54B | Enterprise Value | 27,87B |
Income Statement
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 2,38B | 2,26B | 2,35B | 2,24B | 2,29B |
| Net Income | 770,95M | 858,98M | 1,13B | 42,83M | 619,73M |
| EPS (Diluted) | 1,80 | 1,45 | 2,53 | 0,10 | 1,49 |
| Gross Profit | 2,38B | 2,26B | 2,35B | 2,24B | 2,29B |
| Operating Income | 1,56B | 1,29B | 1,49B | 307,07M | 1,43B |
Balance Sheet
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 19,62B | 18,22B | 16,38B | 16,81B | 17,52B |
| Total Liabilities | 9,91B | 7,88B | 6,30B | 7,29B | 7,27B |
| Shareholders' Equity | 6,48B | 6,95B | 6,53B | 5,63B | 5,78B |
| Total Debt | 8,95B | 7,61B | 6,14B | 7,12B | 7,10B |
| Cash & Equivalents | 618,70M | 929,03M | 477,01M | 1,71B | 1,54B |
| Current Assets | 619,00M | 1,80B | 1,27B | 2,55B | 2,88B |
| Current Liabilities | 636,21M | 1,25B | 161,38M | 1,17B | 171,25M |
Strategiescores
This stock passed the criteria for 1 strategy
Score = fit strength (0–100)
Rank = position among all matches
Custom
Cash Flow Compounder
#346 of 1024
Recente Activiteit
Ingestapt
Cash Flow Compounder
Mar 24, 2026